Difference in score of FOXL1-positive immunostaining was also measured between tumor grades (WD vs PD+MD) and was found to be significant (P<0.05, Figure 1F), with higher FOXL1 scores in WD groups. The gene discussed is FOXL1; the disease is neoplasm.